Ranitidine Hydrochloride
Generic Details
Generic Name
Ranitidine Hydrochloride
Other Names
- Zantac
- Zantac 360
Drug Class
- H2-receptor antagonist
Chemical Formula
C13H23N4O3S.HCl
Molecular Weight
350.87 g/mol
Mechanism of Action
- Blocks histamine H2 receptors, reducing gastric acid secretion
Indications
- Gastric and duodenal ulcers
- Gastroesophageal reflux disease (GERD)
- Zollinger-Ellison Syndrome
- Heartburn
- Indigestion
Common Dosage Forms
- Tablet
- Capsule
- Injection
Typical Dosage
- 150 mg twice daily or 300 mg at bedtime
Pediatric Dosage
- Consult a healthcare provider for appropriate dosing in children
Geriatric Dosage
- Dose adjustment may be needed; consult a healthcare provider
Side Effects
- Headache
- Dizziness
- Constipation
- Diarrhea
- Nausea
Contraindications
- Hypersensitivity to ranitidine or other H2-receptor antagonists
Pregnancy Category
- Category B - Animal reproduction studies have failed to demonstrate a risk to the fetus but no adequate studies in pregnant women
Lactation Safety
- Compatible with breastfeeding; considered safe to use
Drug Interactions
- May interact with antacids, ketoconazole, atazanavir, delavirdine, etc.
Overdose Symptoms
- Bradycardia
- Hypotension
- Confusion
Antidote for Overdose
- Symptomatic and supportive treatment; no specific antidote
Storage Conditions
- Store at room temperature away from moisture and heat
Pharmacokinetics
- Absorption: Rapidly absorbed after oral administration
- Distribution: Widely distributed in the body
- Metabolism: Partially metabolized by the liver
- Excretion: Mainly excreted in the urine
Precautions
- Caution in patients with renal or hepatic impairment
Warnings
- May increase the risk of pneumonia, especially in the elderly
Others
- It is important to seek medical advice before taking ranitidine hydrochloride for prolonged periods.